Botulism/Cost-Effectiveness of Therapy

Jump to navigation Jump to search

MedicalTherapy{{#meta: itemprop="medicalWebPageAudiences" content="patient"}}{{#meta: itemprop="medicalWebPageSpecialities" content="cardiology"}}{{#meta: itemprop="medicalWebPageInfoTypes" content="symptoms,diagnosis,treatment,causes,prognosis,complications"}}




Overview

Botulism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Botulism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Botulism/Cost-Effectiveness of Therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Botulism/Cost-Effectiveness of Therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Botulism/Cost-Effectiveness of Therapy

CDC on Botulism/Cost-Effectiveness of Therapy

Botulism/Cost-Effectiveness of Therapy in the news

Blogs on Botulism/Cost-Effectiveness of Therapy

Directions to Hospitals Treating Botulism

Risk calculators and risk factors for Botulism/Cost-Effectiveness of Therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Hafiz M. Ahmed, M.D.[2]

Overview

The CDC 2021 guideline does not provide a formal cost-effectiveness evaluation of botulism treatments. It describes improved clinical outcomes and reduced hospital resource use associated with early antitoxin treatment, but these findings should not be interpreted as a formal economic comparison of treatment strategies.

References


Template:WikiDoc Sources

  • Adverse Outcomes:
  • Contraindications:
  • Duplicate Therapies:
  • Indications: {{:}}
  • Prevents:
  • Treats:Botulism